Hepatitis C - Hematological Disorders / Neutropenia and Anemia
Open Phase 3 Study of Eltrombopag for Raising Platelet Levels in Patients with Chronic Liver Disease and Thrombocytopenia - 2/27/09 Prodrug Taribavirin Produces Equivalent Response, but Less Anemia than Ribavirin at 48 Weeks - 12/02/2008 Study Demonstrates Safety of Erythropoiesis-stimulating Agents for Managing Ribavirin-related Anemia in Hepatitis C Patients - 7/29/08 Taribavirin Efficacy Similar to Ribavirin in Combination Therapy for Hepatitis C, but with Less Anemia - 5/09/08 Use of Epoetin to Manage Anemia in Chronic Hepatitis C Patients Treated with Pegylated Interferon plus Ribavirin - 8/24/07
Cirrhosis Fibrosis Hepatocellular Carcinoma Liver Transplantation Liver Biopsy Steatosis Anemia Chilren / Infants / Women Drug Abuse Experimental Treatments FAQs About Hepatitis C Genotypes Insulin Resistance / Diabetes Sustained Viral Response (SVR) Tests for HCV Vaccines for HCV
